Risk factors predicting intra-abdominal desmoids in familial adenomatous polyposis: A single centre experience

Techniques in Coloproctology

Volumn 14, Issue 2, 2010, Pages 141-146

  Sinha, A ^a   Tekkis, P P ^b   Neale, K F ^a   Phillips, R K S ^a   Clark, S K ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Desmoid tumour; Familial adenomatous polyposis; Risk factors

Indexed keywords

APC PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL FIBROMATOSIS; ABDOMINAL SURGERY; ADOLESCENT; ADULT; AGE; ARTICLE; COLON POLYPOSIS; COLON RESECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; ILEORECTAL ANASTOMOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROCTOCOLECTOMY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; THERAPY DELAY;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; AGE FACTORS; COHORT STUDIES; COLECTOMY; FEMALE; FIBROMATOSIS, ABDOMINAL; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 77955714083     PISSN: 11236337     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10151-010-0573-4     Document Type: Article

References (26)

1. Kinzler KW, Nilbert MC, Su LK et al (1991) Identification of FAP locus genes from chromosome 5q21. Science 253:661-664
2. Bussey HJ (1987) Historical developments in familial polyposis coli. Semin Surg Oncol 3:67-70
3. Vasen HF, Moslein G, Alonso A et al (2008) Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57:704-713
4. Aziz O, Athanasiou T, Fazio VW et al (2006) Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastamosis for familial adenomatous polyposis. Br J Surg 93:407-417
5. Heiskanen I, Luostarinen T, Jarvinen HJ (2000) Impact of screening examinations on survival in familial adenomatous polyposis. Scand J Gastroenterol 35:1284-1287
6. Bülow S, Bülow C, Nielsen TF et al (1995) Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish polyposis register. Scand J Gastroenterol 30:989-993
7. Sturt NJ, Clark SK (2006) Current ideas in desmoid tumours. Fam Cancer 5:275-285
8. Lofti AM, Dozois RR, Gordon H et al (1989) Mesenteric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatment. Int J Colorectal Dis 4:30-36
9. Bertario L, Russo A, Sala P et al (2001) Genotype and phenotype factors as determinants of desmoid tumours in patients with familial adenomatous polyposis. Int J Cancer 95:102-107
10. Heinimann K, Mullhaupt B, Weber W et al (1998) Phenotypic differences in familial adenomatous polyposis based on APC germline mutation status. Gut 43:675-679
11. Bertario L, Presciuttini S, Sala P et al (1994) Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian registry of familial polyposis writing committee. Semin Surg Oncol 10:225-234
12. Arvanitis ML, Jagelman DG, Fazio VW et al (1990) Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 33:639-642
13. Clark SK, Neale KF, Landgrebe JC et al (1999) Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 86:1185-1189
14. Church JM (1995) Desmoid tumours in patients with familial adenomatous polyposis. Semin Colon Rectal Surg 6:29-32
15. Janinis J, Patriki M, Vini L et al (2003) The pharmacological treatment of aggressive fibromatosis: a systematic review. Ann Oncol 14:181-190
16. Sturt NJH, Gallagher MC, Bassett P et al (2004) Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 53:1832-1836
17. Heiskanen I, Jarvinen HJ (1996) Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorect Dis 11:157-162
18. Lefevre JH, Parc Y, Kerneis S et al (2008) Risk factors for development of desmoid tumours in familial adenomatous polyposis. Br J Surg 95:1136-1139
19. Nieuwenhuis MH, Dees J, Wijnen J et al (2008) Desmoid tumours in a Dutch cohort of patients with familial adenomatous polyposis. Clin Gastro Hep 6:215-219
20. Caspari R, Olschwang S, Friedl W et al (1995) Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Human Mol Genet 4:337-340
21. Durno C, Monga N, Bapat B et al (2007) Does early colectomy increase desmoid risk in familial adenomatous polyposis? Clin Gastro Hep 5:1190-1194
22. Friedl W, Caspari R, Sengteller M et al (2001) Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 48:515-521
23. Hartley JE, Church JM, Gupta S et al (2004) Significance of incidental desmoids identified during surgery for familial adenomatous polyposis. Dis Colon Rectum 47:334-340
24. Bus PJ, Verspaget HW, van Krieken HJM et al (1999) Treatment of mesenteric desmoids with the anti-oestrogenic Toremifene: case histories and an overview of the literature. Eur J Gastroenterol Hepatol 11:1179-1183
25. Hansmann A, Adolph C, Vogel T et al (2004) High dose tamoxifen and sulindac as first-line treatment for desmoid tumours. Cancer 100:612-620
26. Hartley JE, Church JM, Gupta S et al (2004) Significance of incidental desmoids identified during surgery for familial adenomatous polyposis. Dis Colon Rectum 47:334-340